LSPedia 的全球序列化系列
序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.png)
欢迎来到 LspEdia,在这里,创新与奉献精神相结合。
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。

序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。
澳大利亚治疗用品管理局(TGA)是澳大利亚药品监管的基石,隶属于卫生和老年护理部。通过严格执行1989年《治疗用品法》及相关法规,TGA确保澳大利亚市场上的所有治疗产品均符合严格的安全、质量和疗效标准,从而保护公共健康并增强消费者的信心。
TGA要求在进入市场之前对所有治疗产品进行全面评估。这包括临床试验、实验室测试和制造过程审查,以验证安全性、质量和有效性。在合法分销之前,产品必须在澳大利亚治疗用品登记处 (ARTG) 注册。
澳大利亚采用基于风险的方法,对高风险治疗产品进行更严格的审查。这样可以确保最佳的资源分配,同时保持对所有产品类别的监督。TGA的决定以科学证据和专业委员会和国际监管合作伙伴的专家咨询为基础。
TGA通过全面的检查和审计,对国内和国际制造商进行许可和监督。所有设施都必须遵守澳大利亚的良好生产规范 (GMP) 标准,确保药品供应链的完整性和稳定的产品质量。
产品获得批准后,TGA会进行持续监测,以确定新出现的安全问题。该系统包括不良事件报告、产品质量审查和安全评估。当出现担忧时,TGA有权采取监管行动,包括召回或撤出市场。
Our team of compliance experts possesses in-depth knowledge of iTS and Turkish pharmaceutical regulations. From serialization strategies to data reporting, we guide your organization through the intricacies of compliance, ensuring a smooth and informed journey.
Leverage our state-of-the-art compliance solution, designed to integrate seamlessly with iTS requirements. Our technology ensures accuracy, efficiency, and real-time visibility, empowering your organization to meet and exceed compliance expectations.
Compliance is not just about meeting today's standards; it's about preparing for the future. Our solution is designed to evolve with regulatory changes, ensuring that your organization remains at the forefront of compliance in the dynamic Turkish pharmaceutical landscape.
We believe in transparent collaboration. Partner with us, and we'll work closely with your team to implement and maintain compliance measures. Our goal is to build a resilient, compliant, and future-ready pharmaceutical supply chain together.
We invite you to learn more about how LSPedia can support your compliance and supply chain needs. For more information about our solutions, partnership opportunities, or to speak with one of our experts.
Stay connected with us on social media and subscribe to our newsletter to receive the latest updates, insights, and innovations from LSPedia.